NO965531L - FremgangsmÕte til karakterisering av unormale celler - Google Patents

FremgangsmÕte til karakterisering av unormale celler

Info

Publication number
NO965531L
NO965531L NO965531A NO965531A NO965531L NO 965531 L NO965531 L NO 965531L NO 965531 A NO965531 A NO 965531A NO 965531 A NO965531 A NO 965531A NO 965531 L NO965531 L NO 965531L
Authority
NO
Norway
Prior art keywords
target cells
procedure
abnormal cells
cell suspensions
particles
Prior art date
Application number
NO965531A
Other languages
English (en)
Other versions
NO965531D0 (no
NO308755B1 (no
Inventor
Iystein Fodstad
Hanne Kleppe Haaifaadt
Original Assignee
Iystein Fodstad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iystein Fodstad filed Critical Iystein Fodstad
Priority to NO965531A priority Critical patent/NO308755B1/no
Publication of NO965531D0 publication Critical patent/NO965531D0/no
Priority to AT97949270T priority patent/ATE371868T1/de
Priority to CA002275335A priority patent/CA2275335C/en
Priority to AU78752/98A priority patent/AU728190B2/en
Priority to EP97949270A priority patent/EP0951645B1/en
Priority to ES97949270T priority patent/ES2293663T3/es
Priority to PCT/NO1997/000342 priority patent/WO1998028622A1/en
Priority to DE69738076T priority patent/DE69738076T2/de
Publication of NO965531L publication Critical patent/NO965531L/no
Publication of NO308755B1 publication Critical patent/NO308755B1/no
Priority to US11/047,913 priority patent/US8097429B2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO965531A 1996-12-20 1996-12-20 FremgangsmÕte til karakterisering av unormale celler, anvendelse og sett for utførelse av fremgangsmÕten NO308755B1 (no)

Priority Applications (9)

Application Number Priority Date Filing Date Title
NO965531A NO308755B1 (no) 1996-12-20 1996-12-20 FremgangsmÕte til karakterisering av unormale celler, anvendelse og sett for utførelse av fremgangsmÕten
DE69738076T DE69738076T2 (de) 1996-12-20 1997-12-16 Verfahren zur Charakterisierung von Zellen in Suspension
EP97949270A EP0951645B1 (en) 1996-12-20 1997-12-16 Method for characterisation of cells in suspension
CA002275335A CA2275335C (en) 1996-12-20 1997-12-16 Method for characterization of abnormal cells
AU78752/98A AU728190B2 (en) 1996-12-20 1997-12-16 Method for characterization of abnormal cells
AT97949270T ATE371868T1 (de) 1996-12-20 1997-12-16 Verfahren zur charakterisierung von zellen in suspension
ES97949270T ES2293663T3 (es) 1996-12-20 1997-12-16 Procedimiento para la caracterizacion de celulas en suspension.
PCT/NO1997/000342 WO1998028622A1 (en) 1996-12-20 1997-12-16 Method for characterization of abnormal cells
US11/047,913 US8097429B2 (en) 1996-12-20 2005-02-01 Method for characterization of abnormal cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO965531A NO308755B1 (no) 1996-12-20 1996-12-20 FremgangsmÕte til karakterisering av unormale celler, anvendelse og sett for utførelse av fremgangsmÕten

Publications (3)

Publication Number Publication Date
NO965531D0 NO965531D0 (no) 1996-12-20
NO965531L true NO965531L (no) 1998-06-22
NO308755B1 NO308755B1 (no) 2000-10-23

Family

ID=19900214

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965531A NO308755B1 (no) 1996-12-20 1996-12-20 FremgangsmÕte til karakterisering av unormale celler, anvendelse og sett for utførelse av fremgangsmÕten

Country Status (9)

Country Link
US (1) US8097429B2 (no)
EP (1) EP0951645B1 (no)
AT (1) ATE371868T1 (no)
AU (1) AU728190B2 (no)
CA (1) CA2275335C (no)
DE (1) DE69738076T2 (no)
ES (1) ES2293663T3 (no)
NO (1) NO308755B1 (no)
WO (1) WO1998028622A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642062B2 (en) * 1998-09-03 2003-11-04 Trellis Bioinformatics, Inc. Multihued labels
US6828157B1 (en) * 1999-05-04 2004-12-07 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
US6682940B2 (en) * 1999-05-04 2004-01-27 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
GB9913556D0 (en) * 1999-06-11 1999-08-11 Zeneca Ltd Assays
WO2002036833A1 (en) * 2000-11-06 2002-05-10 Bio-Tech Imaging, Inc. Method and kits for detecting hepatitis infected cells
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
KR20030094281A (ko) 2001-03-12 2003-12-11 모노젠, 인크. 세포에 기초한 질병상태의 검출 및 질병상태의 구별
US20030194406A1 (en) * 2001-05-31 2003-10-16 Chiron Corporation P-cadherin as a target for anti-cancer therapy
CA2474509C (en) * 2002-02-14 2012-01-31 Immunivest Corporation Methods and algorithms for cell enumeration in a low-cost cytometer
TW200521433A (en) * 2003-12-22 2005-07-01 We Gene Technologies Inc Cell detection chip and fabricating method thereof and method of detecting cell
US8189899B2 (en) 2004-07-30 2012-05-29 Veridex, Llc Methods and algorithms for cell enumeration in a low-cost cytometer
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
EP2029779A4 (en) 2006-06-14 2010-01-20 Living Microsystems Inc HIGHLY PARALLEL SNP GENOTYPING UTILIZATION FOR FETAL DIAGNOSIS
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
BRPI0807384A2 (pt) * 2007-02-27 2014-05-20 Sentoclone Ab Método de uma etapa para detecção direta ou simultânea de uma célula cancerosa ou elemento de célula cancerosa em uma amostra biológica, kit para uso em um método, base de dados, método para indetificar células cancerosas, e, uso de uma base de dados.
US8664358B2 (en) * 2007-06-29 2014-03-04 Vermillion, Inc. Predictive markers for ovarian cancer
CA3069082C (en) 2008-09-20 2022-03-22 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
CN102432685A (zh) * 2011-11-01 2012-05-02 中国环境科学研究院 检测重组小鼠碱性成纤维细胞生长因子的免疫胶乳微球及其制备方法和应用
JP6310861B2 (ja) * 2012-12-26 2018-04-11 原　正則 尿中ポドサイトの検出方法
DE102013106432A1 (de) * 2013-06-20 2014-12-24 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Optische Indikator-Einheit und Vorrichtung und Verfahren zur Bestimmung einer physikalisch-chemischen Eigenschaft eines Prozessmediums in einer prozesstechnischen Anlage
US20180184950A1 (en) * 2015-04-06 2018-07-05 University Of Miami Imaging device and method for detection of disease

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511662A (en) * 1982-06-18 1985-04-16 Bio-Rad Laboratories, Inc. Simultaneous assay for T and B lymphocyte populations and subpopulations
JPH07104349B2 (ja) * 1987-04-11 1995-11-13 株式会社日立製作所 細胞測定法
US5194300A (en) * 1987-07-15 1993-03-16 Cheung Sau W Methods of making fluorescent microspheres
FR2638848B1 (fr) * 1988-11-04 1993-01-22 Chemunex Sa Procede de detection et/ou de dosage dans un milieu liquide ou semi-liquide d'au moins une substance organique, biologique ou medicamenteuse soluble, par une methode d'agglutination
FR2638849B1 (fr) * 1988-11-04 1994-03-18 Chemunex Sa Procede d'amplification d'un signal fluorescent pour la recherche specifique de la presence eventuelle de particules et application a la detection et a la numeration desdites particules
US5340719A (en) * 1990-11-23 1994-08-23 Corporation Coulter Method and apparatus for optically screening microscopic cells
AU2115092A (en) * 1991-10-08 1993-04-22 Eastman Kodak Company Method, test device and kit for assay of specific binding ligand using controlled flow through filtration membrane
US5290707A (en) * 1991-11-25 1994-03-01 The United States Of America As Represented By The Secretary Of The Army Method for detection of microorganisms
US5256542A (en) * 1992-03-09 1993-10-26 Tanox Biosystems, Inc. Selecting low frequency antigen-specific single B lymphocytes with correction for background noise
DK0723146T3 (da) * 1992-09-14 2004-08-30 Stanford Res Inst Int Opkonverterende reportermolekyler til biologiske og andre assays ved anvendelse af laser-excitationsteknikker
AU2593192A (en) * 1992-09-14 1994-04-12 Oystein Fodstad Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
US5374531A (en) * 1993-03-22 1994-12-20 Zynaxis, Inc. Immunoassay for determination of cells
AUPN214095A0 (en) * 1995-04-03 1995-04-27 Australian Water Technologies Pty Ltd Method for detecting microorganisms using flow cytometry

Also Published As

Publication number Publication date
ATE371868T1 (de) 2007-09-15
WO1998028622A1 (en) 1998-07-02
EP0951645B1 (en) 2007-08-29
US8097429B2 (en) 2012-01-17
CA2275335A1 (en) 1998-07-02
CA2275335C (en) 2008-02-12
AU728190B2 (en) 2001-01-04
DE69738076D1 (de) 2007-10-11
AU7875298A (en) 1998-07-17
DE69738076T2 (de) 2008-05-21
NO965531D0 (no) 1996-12-20
US20050130234A1 (en) 2005-06-16
EP0951645A1 (en) 1999-10-27
ES2293663T3 (es) 2008-03-16
NO308755B1 (no) 2000-10-23

Similar Documents

Publication Publication Date Title
NO965531L (no) FremgangsmÕte til karakterisering av unormale celler
EP0344940A3 (en) Antibodies to human papillomavirus latent proteins, diagnostic systems and methods
DE3579059D1 (de) Apparat zur beschichtung von kernbrennstoffpartikeln mit einem brennbaren absorber.
EP0118894A3 (en) Particle reagent size distribution measurements for immunoassay
EP0956304A4 (en) SPECIFIC ANTIBODIES FOR DENDRITIC CELLS
DK0809807T3 (da) Immunoassay til tælling af celler
CA2093415A1 (en) Test method and reagent kit therefor
CA2146735A1 (en) Liver parenchymal cells having clonal growth ability, method for obtaining same, method for subculturing same, and subculturing system of primary hepatocytes
DE69830602D1 (de) Teilchen
EP0169729A3 (en) Recovery of cell receptors
EP0125893A3 (en) The quantitative analysis of antigen by the enzyme-antibody bridge method
NO172910C (no) Fremgangsmaate for utproeving av en proeve av celler med hensyn til naervaer av celleoverflateantigen
DE69430313D1 (de) Monoklonale antikörper, die flk-2-rezeptoren erkennen, und die isolierung primitiver hämatopoietischer stammzellpopulationen
EP0126429A3 (en) Rotor having a chamber block with an absorbant plug
AU6412098A (en) Methods for identifying cell cycle regulators
Zagury et al. The relationship between storage and secretion of specific antibody by immune lymphoid cells: ultrastructural localization of anti‐peroxidase anti bodies in plaque‐forming cells of the rabbit popliteal lymph node
Englebienne et al. An improved method for isolation of specific antibodies by affinity chromatography; application to an antiserum to testosterone
DK481484D0 (da) Fremgangsmaade til paavisning af virus
WO2004047721A3 (en) A process for preparation of an agglutination reagent for rapid detection of typhoid
Samain et al. Model for Rapid Detection of Sublethal Effects of Pollutants. II. An In Situ Example: Anomalous Metabolism of the Hyponeustonic Copepod Anomalocera patersoni Coinciding With an Oil Spill.
IL141858A0 (en) Diagnostic method for detecting disturbances of the pancreas
FI843562A0 (fi) Foerfarande foer immunokemisk bestaemning av hepatitis b kaernantigener.
DE59913949D1 (de) Humane monoklonale antikörper gegen inselzellantigen ia-2
Lombardini Repairs of Pipelines During Service by Welding
JPS5634929A (en) Gas turbine engine air inlet port with granular substance separator

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees